VTD-PACE regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} ==Overview== {{PAGENAME}} refers to a regimen consisting of bortezomib (Velcade), thalidomide, dexamethasone, [..." |
No edit summary |
||
Line 6: | Line 6: | ||
{{PAGENAME}} refers to a regimen consisting of [[Bortezomib|bortezomib (Velcade)]], [[thalidomide]], [[dexamethasone]], [[cisplatin|Platinum (cisplatin)]], [[doxorubicin|Adriamycin (doxorubicin)]], [[cyclophosphamide]], [[etoposide]] used to treat [[multiple myeloma]] | {{PAGENAME}} refers to a regimen consisting of [[Bortezomib|bortezomib (Velcade)]], [[thalidomide]], [[dexamethasone]], [[cisplatin|Platinum (cisplatin)]], [[doxorubicin|Adriamycin (doxorubicin)]], [[cyclophosphamide]], [[etoposide]] used to treat [[multiple myeloma]] | ||
. | . | ||
==Regimen== | ==Regimen== | ||
{{chemo|V|Bortezomib (Velcade)}} | {{chemo|V|Bortezomib (Velcade)}} | ||
{{chemo|T|Thalidomide}} | |||
{{chemo|D|Dexamethasone}} | {{chemo|D|Dexamethasone}} | ||
{{chemo|P|Platinum (cisplatin)}} | {{chemo|P|Platinum (cisplatin)}} | ||
Line 23: | Line 22: | ||
==Indications== | ==Indications== | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Chemotherapy regimens]] | [[Category:Chemotherapy regimens]] |
Revision as of 13:09, 30 March 2015
WikiDoc Resources for VTD-PACE regimen |
Articles |
---|
Most recent articles on VTD-PACE regimen Most cited articles on VTD-PACE regimen |
Media |
Powerpoint slides on VTD-PACE regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on VTD-PACE regimen at Clinical Trials.gov Trial results on VTD-PACE regimen Clinical Trials on VTD-PACE regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on VTD-PACE regimen NICE Guidance on VTD-PACE regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on VTD-PACE regimen Discussion groups on VTD-PACE regimen Patient Handouts on VTD-PACE regimen Directions to Hospitals Treating VTD-PACE regimen Risk calculators and risk factors for VTD-PACE regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for VTD-PACE regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
VTD-PACE regimen refers to a regimen consisting of bortezomib (Velcade), thalidomide, dexamethasone, Platinum (cisplatin), Adriamycin (doxorubicin), cyclophosphamide, etoposide used to treat multiple myeloma .
Regimen
VBortezomib (Velcade)
TThalidomide
DDexamethasone
PPlatinum (cisplatin)
AAdriamycin (doxorubicin)
CCyclophosphamide
EEtoposide